• A Pöting and M Schauzu.
• Bundesinstitut für Risikobewertung, Berlin. annette.poeting@bfr.bund.de
• Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jun 1; 53 (6): 583-8.

AbstractThe placing of genetically modified plants and derived food on the market falls under Regulation (EC) No. 1829/2003. According to this regulation, applicants need to perform a safety assessment according to the Guidance Document of the Scientific Panel on Genetically Modified Organisms of the European Food Safety Authority (EFSA), which is based on internationally agreed recommendations. This article gives an overview of the underlying legislation as well as the strategy and scientific criteria for the safety assessment, which should generally be based on the concept of substantial equivalence and carried out in relation to an unmodified conventional counterpart. Besides the intended genetic modification, potential unintended changes also have to be assessed with regard to potential adverse effects for the consumer. All genetically modified plants and derived food products, which have been evaluated by EFSA so far, were considered to be as safe as products derived from the respective conventional plants.

16 keywords...

hide…